By ABBY GOODNOUGH and MARGOT SANGER-KATZ
The agency, whose oversight of opioid safety has largely eluded scrutiny, did not improve flawed programs designed to reduce addiction and overdoses.
Published: December 29, 2019 at 07:00PM
from NYT Health https://ift.tt/37jUCig
via IFTTT
from WordPress https://ift.tt/2Q9twEF
via IFTTT
No comments:
Post a Comment